In June 2015, Vaccinex, the Huntington Study Group (HSG), and the University of Rochester’s Clinical Trials Coordination Center (CTCC) launched SIGNAL, the first clinical trial to investigate a The post Vaccinex announces completion of enrollment for SIGNAL Huntington’s disease trial appeared first on Pharmaceutical Business review.
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been The post ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors appeared first on Pharmaceutical Business review.
Under the deal, Spectrum will secure $160m in an upfront cash payment, while up to $140m in regulatory and sales-based milestones. Spectrum Pharmaceuticals president and CEO Joe Turgeon The post Acrotech to buy seven hematology/oncology products from Spectrum appeared first on Pharmaceutical Business review.
Through the investment, Schott plans to expand its primary business of glass tubing, used as the starting material for pharmaceutical packaging, and also pharmaceutical packaging made of glass and The post Schott to invest €300m in pharmaceutical packaging buisness appeared first on Pharmaceutical Business review.
Abbott (NYSE:ABT) said today that it has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country’s blood donations. The eight-year contract is for the exclusive supply of serological instrumentation, tests, and consumables used for blood and plasma screening. The JRC screens approximately 5 million blood donations each year, helping ensure a […]
Windgap Medical has raised $12 million from 106 investors as part of a $27 million round, according to a document filed with the SEC. The Watertown, Mass.-based company is developing an epinephrine auto-injector designed to treat severe allergic reactions. Get the full story at our sister site, Drug Delivery Business News. The post Windgap Medical raises $12m for […]
HighLife said today that it raised a Series B round worth more than $36 million for the transcatheter mitral valve replacement it’s developing. HighLife’s TMVR uses a ring around the diseased valve’s leaflets that’s designed to guide the replacement valve into position. It’s designed to be delivered through the inter-atrial septum, rather than via a trans-apical […]
LivaNova (NSDQ:LIVN) said today that three separate, recently published studies highlight the performance and cost savings of its sutureless aortic valve, Perceval. The results from the Perceval Aortic Heart Valve Study in North America found that Perceval achieves positive safety and efficacy outcomes whether or not an open or minimally invasive surgical approach is used. The […]
OtoNexus (Seattle) has raised more than $4.4 million as it continues to develop its ultrasound medical device technology to diagnose middle ear infections, according to a U.S. Securities and Exchange Commission Form D filed this month. OtoNexus has been seeking a nearly $8.3 million from the money-raise. It previously raised $7.8 million in 2017. Get the full […]
Johnson & Johnson‘s (NYSE:JNJ) Janssen and Apple (NSDQ:AAPL) said today that the two companies inked a deal to study if an app from J&J in combination with the Apple Watch’s ECG app and irregular rhythm notifications can improve outcomes for people living with atrial fibrillation. The study is slated to measure the impact of the Apple Watch on the […]